Potential for trials in Russia "enormous", says ClinStar

By Gareth Macdonald

- Last updated on GMT

Related tags: Russia, Clinical trial

Potential for trials in Russia "enormous", says ClinStar
Russia, the Ukraine and Belarus have emerged as destinations for clinical studies and now offer “enormous” potential according to US-based CRO ClinStar.

Roger Price, director of European business development director at the contract research organisation (CRO) told Outsourcing-pharma that because fewer trials are conducted in the region there is less competition for patients than in the US.

Price also said that the legacy of the USSR's centralised system means that across the region health care provision is focused at key hubs which, he suggested, offers significant benefits in terms of both recruitment and monitoring.

He explained that: “When we do a study we can go to these hospitals, they have databases and we can access those [patients​]” and added that developing effective relationships with such institutions is critical to success in the region.

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us

Products

View more

Webinars